argenx (ARGX) Tops Q3 EPS by 124c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall St futures jump as Democrats sweep midterms
- CVS Health plans to split into two public companies by 2028
- UBS starts bullish coverage on Ferrari Group on luxury logistics growth
- Citi cuts Adobe rating on ’rising risk of a hard reset’
- Apple shares slip amid guidance for tightening margins, slowing services growth
- AMD gets bullish pre-earnings call from Lynx as server CPU demand accelerates
- Marathon Petroleum to sell two refineries to CVR Energy for $4.2B
- AMD forecast eases AI spending fears as data-center sales surge
- Moderna shares rise ahead of Thursday earnings report
- Broadcom shares climb as AI chip financing deal supports rally
- After-Hours Movers: AMD, SMCI, SWKS, NRIX, TOST, BKNG
- After-Hours Movers: AMZN, TWLO, INTC, SNDK, RDDT, RBLX, PINS, RIVN, SBUX, ILMN
- After-Hours Movers: GOOGL, MSFT, NOW, KLAC. CMG, CVNA, TDOC
- After-Hours Movers: STX, ENPH, HOOD, V, CSGP, BOOM, CAKE, PPG, OI, TER
- After-Hours Movers: CLS, AVGO, CDNS, AMKR, WHR
argenx SE (ARGX) PT Raised to $635 at Leerink Partners
November 1, 2024 7:22 AM EDTLeerink Partners analyst Thomas J. Smith raised the price target on argenx SE (NASDAQ: ARGX) to $635.00 (from $550.00) while maintaining a Outperform rating.
The analyst comments "Bottom Line: ARGX (OP) reported yet another strong quarter of Vyvgart sales, beating consensus expectations for the 11th consecutive quarter (see our quick take HERE). Notably, this marked the first full quarter of Vyvgart Hytrulo sales in CIDP, and... More
Raymond James Reiterates Strong Buy Rating on argenx SE (ARGX)
October 31, 2024 1:15 PM EDTRaymond James analyst Danielle Brill reiterated an Strong Buy rating on argenx SE (NASDAQ: ARGX).
The analyst comments "3Q24 Vyvgart revenues of $573M (+20% q/q) swiftly beat our $513M and consensus $520M estimates. Growth momentum remains strong in the gMG segment and... More



